Ikarian Capital, LLC Rezolute, Inc. Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 50,058 shares of RZLT stock, worth $281,826. This represents 0.02% of its overall portfolio holdings.
Number of Shares
50,058
Previous 857,230
94.16%
Holding current value
$281,826
Previous $4.09 Million
96.45%
% of portfolio
0.02%
Previous 0.67%
Shares
4 transactions
Others Institutions Holding RZLT
# of Institutions
82Shares Held
39.7MCall Options Held
402KPut Options Held
19.4K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$63.5 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$13.4 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.11MShares$11.9 Million1.66% of portfolio
-
Marshall Wace, LLP London, X01.85MShares$10.4 Million0.01% of portfolio
-
Blackstone Inc New York, NY1.74MShares$9.82 Million0.02% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $219M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...